Back
Vaccinex 10K Form
Sell
44
VCNX
Vaccinex
Last Price:
3.60
Seasonality Move:
2.9%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-08-14 | 10Q | VCNX/Vaccinex Quarterly |
| 2020-05-14 | 10Q | VCNX/Vaccinex Quarterly |
| 2020-03-09 | 10K | VCNX/Vaccinex Annual |
| 2019-11-12 | 10Q | VCNX/Vaccinex Quarterly |
| 2019-08-14 | 10Q | VCNX/Vaccinex Quarterly |
| 2019-05-15 | 10Q | VCNX/Vaccinex Quarterly |
Receive VCNX News And Ratings
See the #1 stock for the next 7 days that we like better than VCNX
VCNX Financial Statistics
Sales & Book Value
| Annual Sales: | $570K |
|---|---|
| Cash Flow: | $-4.43M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-2.68 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -25.01600 |
|---|---|
| Net Income (TTM): | $-17.76M |
| Gross Margin: | $900K |
| Return on Equity: | 0% |
| Return on Assets: | -467.09% |
Vaccinex Earnings Forecast
Key Vaccinex Financial Ratios
- The Gross Profit Margin over the past 6 years for VCNX is 100.00%.
- The Selling, General & Administrative Expenses for VCNX have been equal to 1,207.19% of Gross Profit Margin.
- The Research & Development expenses have been 2,907.72% of Revenue.
- The Interest Expense is 0.00% of Operating Income.
- The Net Earning history of VCNX is -3,552.81% of Total Revenues.
- Per Share Earnings over the last 8 years have been positive in 6 years.
Vaccinex Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | VCNX |
| CUSIP: | 918640 |
| Website: | vaccinex.com |
Debt
| Debt-to-Equity Ratio: | -0.02 |
|---|---|
| Current Ratio: | 0.42 |
| Quick Ratio: | 0.24 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |